507 related articles for article (PubMed ID: 33330019)
1. MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review.
Volovat SR; Volovat C; Hordila I; Hordila DA; Mirestean CC; Miron OT; Lungulescu C; Scripcariu DV; Stolniceanu CR; Konsoulova-Kirova AA; Grigorescu C; Stefanescu C; Volovat CC; Augustin I
Front Oncol; 2020; 10():526850. PubMed ID: 33330019
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
4. Interactions among lncRNAs, miRNAs and mRNA in colorectal cancer.
Tang XJ; Wang W; Hann SS
Biochimie; 2019 Aug; 163():58-72. PubMed ID: 31082429
[TBL] [Abstract][Full Text] [Related]
5. Genomic Alterations Affecting Competitive Endogenous RNAs (ceRNAs) and Regulatory Networks (ceRNETs) with Clinical Implications in Triple-Negative Breast Cancer (TNBC).
Qattan A
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473871
[TBL] [Abstract][Full Text] [Related]
6. Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer.
Song X; Zhang C; Liu Z; Liu Q; He K; Yu Z
PeerJ; 2019; 7():e7522. PubMed ID: 31565554
[TBL] [Abstract][Full Text] [Related]
7. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide identification and comparison of differentially expressed profiles of miRNAs and lncRNAs with associated ceRNA networks in the gonads of Chinese soft-shelled turtle, Pelodiscus sinensis.
Ma X; Cen S; Wang L; Zhang C; Wu L; Tian X; Wu Q; Li X; Wang X
BMC Genomics; 2020 Jun; 21(1):443. PubMed ID: 32600250
[TBL] [Abstract][Full Text] [Related]
9. RNA atlas and competing endogenous RNA regulation in tissue-derived exosomes from luminal B and triple-negative breast cancer patients.
Wang J; Zhang X; You Z; Meng Y; Fan X; Qiao G; Pang D
Front Oncol; 2023; 13():1113115. PubMed ID: 37483500
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
11. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
[TBL] [Abstract][Full Text] [Related]
12. LncmiRSRN: identification and analysis of long non-coding RNA related miRNA sponge regulatory network in human cancer.
Zhang J; Liu L; Li J; Le TD
Bioinformatics; 2018 Dec; 34(24):4232-4240. PubMed ID: 29955818
[TBL] [Abstract][Full Text] [Related]
13. Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: A review.
Saranya I; Dharshini VS; Akshaya RL; Subhashini PS; Selvamurugan N
Int J Biol Macromol; 2024 May; 266(Pt 2):131075. PubMed ID: 38531528
[TBL] [Abstract][Full Text] [Related]
14. Gene and lncRNA co-expression network analysis reveals novel ceRNA network for triple-negative breast cancer.
Le K; Guo H; Zhang Q; Huang X; Xu M; Huang Z; Yi P
Sci Rep; 2019 Oct; 9(1):15122. PubMed ID: 31641220
[TBL] [Abstract][Full Text] [Related]
15. Identification and functional characterization of lncRNAs acting as ceRNA involved in the malignant progression of glioblastoma multiforme.
Zhang K; Li Q; Kang X; Wang Y; Wang S
Oncol Rep; 2016 Nov; 36(5):2911-2925. PubMed ID: 27600337
[TBL] [Abstract][Full Text] [Related]
16. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue.
Zhou RS; Zhang EX; Sun QF; Ye ZJ; Liu JW; Zhou DH; Tang Y
BMC Cancer; 2019 Aug; 19(1):779. PubMed ID: 31391008
[TBL] [Abstract][Full Text] [Related]
17. Noncoding RNAs in triple negative breast cancer: Mechanisms for chemoresistance.
Xia M; Zu X; Chen Z; Wen G; Zhong J
Cancer Lett; 2021 Dec; 523():100-110. PubMed ID: 34601022
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of differentially expressed profiles of lncRNAs, mRNAs, and miRNAs in laryngeal squamous cell carcinoma in order to construct a ceRNA network and identify potential biomarkers.
Kong X; Qi J; Yan Y; Chen L; Zhao Y; Fang Z; Fan J; Liu M; Liu Y
J Cell Biochem; 2019 Oct; 120(10):17963-17974. PubMed ID: 31127661
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of lncRNA Expression Pattern and lncRNA-miRNA-mRNA Network in a Rat Model With Cavernous Nerve Injury Erectile Dysfunction.
Cong R; Wang Y; Wang Y; Zhang Q; Zhou X; Ji C; Yao L; Song N; Meng X
J Sex Med; 2020 Sep; 17(9):1603-1617. PubMed ID: 32675050
[TBL] [Abstract][Full Text] [Related]
20. Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer.
Conte F; Fiscon G; Chiara M; Colombo T; Farina L; Paci P
PLoS One; 2017; 12(2):e0171661. PubMed ID: 28187158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
